From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer - Top-Institutions - MDSpire

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

  • By

  • Ming Jin

  • Zhenzhen Cai

  • Ming Bu

  • Jicheng Liu

  • Xiaojie Zhang

  • May 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    University of Southern California
    University of Southern California

    Los Angeles, California

    Key Differentiators

    • Oncology

  • #4

    San Raffaele Hospital
    San Raffaele Hospital

    Milan, Italy

    Key Differentiators

    • Oncology

  • #5

    Princess Margaret Cancer Centre
    Princess Margaret Cancer Centre

    Toronto, Ontario

    Key Differentiators

    • Oncology

Original Source(s)

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

  • by Ming Jin, Zhenzhen Cai, Ming Bu, Jicheng Liu, Xiaojie Zhang

  • May 29, 2026

Related Content

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate